A round-up of some of the latest advances in cancer reseacher presented by MSK scientists at the 2026 American Association ...
Every day, the people of Memorial Sloan Kettering Cancer Center (MSK) are driven by a singular mission: ending cancer for life. That relentless focus enables us to provide the world’s best, most ...
One of only four fully digital MSK platforms selected for the federal initiative launching July 5, 2026 ...
Memorial Sloan Kettering Cancer Center is proud to announce the formation of MSK Ventures, a dedicated venture capital fund launching in 2026. MSK Ventures is designed to invest in high-conviction ...
A personalized mRNA vaccine from Memorial Sloan Kettering Cancer Center has shown unprecedented six-year survival rates in a ...
Nothing feels more enchanting in November than entering the golden-hued Grand Ballroom of the Plaza Hotel for The Society of Memorial Sloan Kettering’s annual Fall Party. For the second year in a row ...
The Society of Memorial Sloan-Kettering (MSK) held its 16th Annual Spring Ball on Thursday night, in the freshly redone ballroom of the Pierre Hotel, where 430 guests came out to support this ...
DarioHealth buys into MSK with Upright Technologies acquisition and announces $70M private placement
DarioHealth announced today that it is expanding its digital chronic-disease-management business beyond diabetes and hypertension with the purchase of Upright Technologies, a musculoskeletal (MSK) ...
As part of an AHIP announcement April 7 outlining industry–wide efforts to modernize prior authorization, American Specialty Health (ASH) emerged as a key partner working alongside the national trade ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results